Home › Lymphoma › Nebraska
Lymphoma clinical trials in Nebraska
7 studies for Lymphoma are looking for participants at sites in Nebraska.
Cities in Nebraska
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of Nebraska Medical Center, Omaha
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
- University of Nebraska Medical Center, Omaha
Recruiting
Ages 19 and older · All sexes · Updated Aug 19, 2026 · NCT04898790A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
- University of Nebraska Medical Center, Omaha
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06528301A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- University of Nebraska Medical Center (UNMC), Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07188558Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy
- Unversity of Nebraska Medical Center, Omaha
Recruiting
Ages 19 and older · All sexes · Updated Jul 27, 2026 · NCT05135351CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Fred and Pamela Buffett Cancer Center, Omaha
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
RecruitingPhase 1/2
Ages 12 to 95 · All sexes · Updated Apr 15, 2026 · NCT04329728From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.